Cargando…

Available drugs and supplements for rapid deployment for treatment of COVID-19

Detalles Bibliográficos
Autores principales:	Cicka, Danielle, Sukhatme, Vikas P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928750/ https://www.ncbi.nlm.nih.gov/pubmed/33493301 http://dx.doi.org/10.1093/jmcb/mjab002

Ejemplares similares

Safety and Considerations of the COVID-19 Vaccine Massive Deployment
por: Li, Junwei, et al.
Publicado: (2021)

Considerations for Assessment and Deployment of Rapid Antigen Tests for Diagnosis of Coronavirus Disease 2019
por: Pollock, Nira R, et al.
Publicado: (2021)

The impact of the acceleration of COVID-19 vaccine deployment in two border regions in Oman
por: Al Rawahi, Bader, et al.
Publicado: (2022)

Corticosteroids Use in Pregnant Women with COVID-19: Recommendations from Available Evidence
por: Magala Ssekandi, Abdul, et al.
Publicado: (2021)

The Repurposing Drugs in Oncology (ReDO) Project
por: Pantziarka, Pan, et al.
Publicado: (2014)

Does clinical research account for diversity in deploying digital health technologies?
por: Coss, Nathan A., et al.
Publicado: (2023)

Availability and use of Standards in vaccine development
por: Avumegah, Michael Selorm, et al.
Publicado: (2023)

Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
por: Sukhatme, Vikas P., et al.
Publicado: (2021)

Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent
por: Sukhatme, Vidula, et al.
Publicado: (2015)

Accelerated Preclinical Paths to Support Rapid Development of COVID-19 Therapeutics
por: Grobler, Jay A., et al.
Publicado: (2020)

Mitigating COVID-19 Mortality and Morbidity in China's Aging Population: A Focus on Available Medications and Future Developments
por: Bischof, Evelyne
Publicado: (2023)

Rapid Antigen Diagnostics as Frontline Testing in the COVID‐19 Pandemic
por: Xu, Jiang, et al.
Publicado: (2022)

Precision oncology: Charting a path forward to broader deployment of genomic profiling
por: Schram, Alison M., et al.
Publicado: (2017)

Memorialising COVID-19
por: Ofri, Danielle
Publicado: (2022)

Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs
por: Fessel, Jeffrey
Publicado: (2019)

Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

COVID-19 and Nanoscience in the Developing World: Rapid Detection and Remediation in Wastewater
por: Adeel, Muhammad, et al.
Publicado: (2021)

Initial rapid and proactive response for the COVID-19 outbreak — Taiwan's experience
por: Cheng, Hao-Yuan, et al.
Publicado: (2020)

Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease
por: Hill, Derek L., et al.
Publicado: (2022)

Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent
por: Van Nuffel, An MT, et al.
Publicado: (2015)

Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as anti-cancer agents
por: Pantziarka, Pan, et al.
Publicado: (2018)

The Critical Factors Affecting the Deployment and Scaling of Healthcare AI: Viewpoint from an Experienced Medical Center
por: Liu, Chung-Feng, et al.
Publicado: (2021)

Effective deployment of technology-supported management of chronic respiratory conditions: a call for stakeholder engagement
por: Costello, Richard W, et al.
Publicado: (2017)

Rapid response of a medical center upon the surge of COVID-19 epidemic in Taiwan
por: Huang, Jih-Hsin, et al.
Publicado: (2022)

Deploying digital health tools within large, complex health systems: key considerations for adoption and implementation
por: Marwaha, Jayson S., et al.
Publicado: (2022)

Supply chain transparency and the availability of essential medicines
por: Årdal, Christine, et al.
Publicado: (2021)

Riding the rapids: COVID‐19, the three rivers curriculum, and the experiences of the University of Pittsburgh School of Medicine
por: Elnicki, D. Michael, et al.
Publicado: (2021)

Ivermectin as a multifaceted drug in COVID-19: Current insights
por: Khandelwal, Ankur, et al.
Publicado: (2021)

Accelerating antiviral drug discovery: lessons from COVID-19
por: von Delft, Annette, et al.
Publicado: (2023)

Two Pandemics, One Challenge—Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding
por: Homolka, Susanne, et al.
Publicado: (2020)

Rapid synthesis of a changing evidence base during the COVID-19 pandemic: the NeoCLEAR Project
por: Kirkley, Megan J., et al.
Publicado: (2021)

Off the Shelf: Rapid Deployment of an Emergency Department Telemedicine Platform Using Readily Available Consumer Products
por: Lowe, Jason, et al.
Publicado: (2020)

Can food and food supplements be deployed in the fight against the COVID 19 pandemic?
por: Celik, Cagla, et al.
Publicado: (2021)

The Covid-19 infection: An opportunity to develop systematic vitamin D supplementation in psychiatry
por: Fond, G., et al.
Publicado: (2022)

Rapid Appraisal System for COVID-19 Medical Information
por: Razonable, Raymund R., et al.
Publicado: (2020)

A Call to Improve Usability, Accuracy, and Equity of Self-Testing for COVID-19 and Other Rapid Diagnostic Tests
por: Drain, Paul K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1n05059u0ndsnhng4p1d0ctoh3